NDC properties for NDC 9 24208-819
NDC item 24208081905
NDC 9 | 24208-819 |
---|---|
NDC 10 | 24208-819-05 |
NDC Item | 24208081905 |
packaging | 1 BOTTLE, DISPENSING in 1 CARTON (24208-819-05) / 5 mL in 1 BOTTLE, DISPENSING |
FDA SPL set id | 567541 |
Labeler | Bausch & Lomb Incorporated |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2018-02-14 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA020330 |
NDC item 43598074811
NDC 9 | 43598-748 |
---|---|
NDC 10 | 43598-748-11 |
NDC Item | 43598074811 |
packaging | 1 BOTTLE in 1 CARTON (43598-748-11) / 5 mL in 1 BOTTLE |
ANDA | ANDA215733 |
FDA SPL set id | 793699 |
Labeler | Dr. Reddy's Laboratories, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-15 |
Marketing status | ACTIVE |
NDC item 59651031305
NDC 9 | 59651-313 |
---|---|
NDC 10 | 59651-313-05 |
NDC Item | 59651031305 |
packaging | 1 BOTTLE, DISPENSING in 1 CARTON (59651-313-05) / 5 mL in 1 BOTTLE, DISPENSING |
ANDA | ANDA213540 |
FDA SPL set id | 786918 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-23 |
Marketing status | ACTIVE |
NDC item 60219137603
NDC 9 | 60219-1376 |
---|---|
NDC 10 | 60219-1376-3 |
NDC Item | 60219137603 |
packaging | 1 BOTTLE, DROPPER in 1 CARTON (60219-1376-3) / 5 mL in 1 BOTTLE, DROPPER |
ANDA | ANDA216343 |
FDA SPL set id | 801975 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-05-27 |
Marketing status | ACTIVE |
NDC item 60219205503
NDC 9 | 60219-2055 |
---|---|
NDC 10 | 60219-2055-3 |
NDC Item | 60219205503 |
packaging | 1 BOTTLE, DROPPER in 1 CARTON (60219-2055-3) / 2.5 mL in 1 BOTTLE, DROPPER |
ANDA | ANDA216343 |
FDA SPL set id | 801975 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-05-27 |
Marketing status | ACTIVE |
NDC item 61314022505
NDC 9 | 61314-225 |
---|---|
NDC 10 | 61314-225-05 |
NDC Item | 61314022505 |
packaging | 5 mL in 1 BOTTLE (61314-225-05) |
FDA SPL set id | 790292 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 1998-12-24 |
Marketing status | ACTIVE |
NDA | NDA020963 |
NDC item 61314022525
NDC 9 | 61314-225 |
---|---|
NDC 10 | 61314-225-25 |
NDC Item | 61314022525 |
packaging | 2.5 mL in 1 BOTTLE (61314-225-25) |
FDA SPL set id | 790292 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 1998-12-24 |
Marketing status | ACTIVE |
NDA | NDA020963 |
NDC item 62332054605
NDC 9 | 62332-546 |
---|---|
NDC 10 | 62332-546-05 |
NDC Item | 62332054605 |
packaging | 1 BOTTLE in 1 CARTON (62332-546-05) / 5 mL in 1 BOTTLE |
ANDA | ANDA212942 |
FDA SPL set id | 647002 |
Labeler | Alembic Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-11-22 |
Marketing status | ACTIVE |
NDC item 68083045801
NDC 9 | 68083-458 |
---|---|
NDC 10 | 68083-458-01 |
NDC Item | 68083045801 |
packaging | 1 BOTTLE in 1 CARTON (68083-458-01) / 5 mL in 1 BOTTLE |
ANDA | ANDA214645 |
FDA SPL set id | 695465 |
Labeler | Gland Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-02-14 |
Marketing status | ACTIVE |
NDC item 70069025101
NDC 9 | 70069-251 |
---|---|
NDC 10 | 70069-251-01 |
NDC Item | 70069025101 |
packaging | 1 BOTTLE in 1 CARTON (70069-251-01) / 5 mL in 1 BOTTLE |
ANDA | ANDA210640 |
COLORTEXT | WHITE(slightly viscous colorless solution) |
Color | C48325 __ |
FDA SPL set id | 827170 |
Labeler | Somerset Therapeutics, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-10-31 |
Marketing status | ACTIVE |
NDC item 72162218502
NDC 9 | 72162-2185 |
---|---|
NDC 10 | 72162-2185-2 |
NDC Item | 72162218502 |
packaging | 5 mL in 1 BOTTLE (72162-2185-2) |
FDA SPL set id | 800568 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 1998-12-24 |
Marketing status | ACTIVE |
NDA | NDA020963 |
NDC item 72266020001
NDC 9 | 72266-200 |
---|---|
NDC 10 | 72266-200-01 |
NDC Item | 72266020001 |
packaging | 1 BOTTLE in 1 CARTON (72266-200-01) / 5 mL in 1 BOTTLE |
ANDA | ANDA214645 |
FDA SPL set id | 866357 |
Labeler | FOSUN PHARMA USA INC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-15 |
Marketing status | ACTIVE |
NDC item 72603016301
NDC 9 | 72603-163 |
---|---|
NDC 10 | 72603-163-01 |
NDC Item | 72603016301 |
packaging | 1 BOTTLE in 1 CARTON (72603-163-01) / 5 mL in 1 BOTTLE |
ANDA | ANDA215733 |
FDA SPL set id | 747523 |
Labeler | NorthStar RxLLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-08-14 |
Marketing status | ACTIVE |
NDC item 82260081905
NDC 9 | 82260-819 |
---|---|
NDC 10 | 82260-819-05 |
NDC Item | 82260081905 |
packaging | 1 BOTTLE, DISPENSING in 1 CARTON (82260-819-05) / 5 mL in 1 BOTTLE, DISPENSING |
FDA SPL set id | 867085 |
Labeler | Bausch & Lomb Americas Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2018-02-14 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA020330 |